{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:28:29Z","timestamp":1774038509091,"version":"3.50.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T00:00:00Z","timestamp":1396828800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0093743","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T23:06:33Z","timestamp":1396911993000},"page":"e93743","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Relaxin Does Not Improve Angiotensin II-Induced Target-Organ Damage"],"prefix":"10.1371","volume":"9","author":[{"given":"Nadine","family":"Haase","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julianna","family":"Rugor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukasz","family":"Przybyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatimunnisa","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik N.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Dechend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,4,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"R267","DOI":"10.1152\/ajpregu.00156.2011","article-title":"Maternal vasodilation in pregnancy: the emerging role of relaxin","volume":"301","author":"KP Conrad","year":"2011","journal-title":"American journal of physiology Regulatory, integrative and comparative physiology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"R250","DOI":"10.1152\/ajpregu.00672.2003","article-title":"Emerging role of relaxin in renal and cardiovascular function","volume":"287","author":"KP Conrad","year":"2004","journal-title":"American journal of physiology Regulatory, integrative and comparative physiology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/sj.ki.5000264","article-title":"Relaxin in cardiovascular and renal disease","volume":"69","author":"CS Samuel","year":"2006","journal-title":"Kidney international"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00018-007-6543-y","article-title":"Drugs of the future: the hormone relaxin","volume":"64","author":"CS Samuel","year":"2007","journal-title":"Cellular and molecular life sciences: CMLS"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0008-6363(02)00663-6","article-title":"Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype","volume":"57","author":"XJ Du","year":"2003","journal-title":"Cardiovascular research"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"JR Teerlink","year":"2013","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(09)60622-X","article-title":"Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study","volume":"373","author":"JR Teerlink","year":"2009","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.semnephrol.2010.10.003","article-title":"Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia","volume":"31","author":"KP Conrad","year":"2011","journal-title":"Semin Nephrol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1749-6632.2009.03838.x","article-title":"Scientific rationale and design of a phase I safety study of relaxin in women with severe preeclampsia","volume":"1160","author":"E Unemori","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/HYPERTENSIONAHA.111.171348","article-title":"Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats","volume":"58","author":"K Wenzel","year":"2011","journal-title":"Hypertension"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1172\/JCI107462","article-title":"A study of angiotensin II pressor response throughout primigravid pregnancy","volume":"52","author":"NF Gant","year":"1973","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/HYPERTENSIONAHA.107.103143","article-title":"Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension","volume":"51","author":"R Fischer","year":"2008","journal-title":"Hypertension"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/01.HYP.33.1.212","article-title":"Hypertension-induced end-organ damage: A new transgenic approach to an old problem","volume":"33","author":"FC Luft","year":"1999","journal-title":"Hypertension"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0002-9440(10)64445-8","article-title":"Immunosuppressive treatment protects against angiotensin II-induced renal damage","volume":"161","author":"DN Muller","year":"2002","journal-title":"The American journal of pathology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1152\/physiolgenomics.00165.2004","article-title":"Cardiac gene expression profile in rats with terminal heart failure and cachexia","volume":"20","author":"M Wellner","year":"2005","journal-title":"Physiological genomics"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0002-9440(10)64523-3","article-title":"Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy","volume":"157","author":"DN Muller","year":"2000","journal-title":"The American journal of pathology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/01.RES.0000182677.89816.38","article-title":"Complement activation in angiotensin II-induced organ damage","volume":"97","author":"E Shagdarsuren","year":"2005","journal-title":"Circulation research"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/01.HYP.35.1.193","article-title":"NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats","volume":"35","author":"DN Muller","year":"2000","journal-title":"Hypertension"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/hc3001.092039","article-title":"Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor","volume":"104","author":"R Dechend","year":"2001","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1210\/en.2010-1126","article-title":"Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide","volume":"152","author":"JT McGuane","year":"2011","journal-title":"Endocrinology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1161\/CIRCULATIONAHA.108.832782","article-title":"Regulatory T cells ameliorate angiotensin II-induced cardiac damage","volume":"119","author":"H Kvakan","year":"2009","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.HYP.37.2.414","article-title":"Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes","volume":"37","author":"EM Mervaala","year":"2001","journal-title":"Hypertension"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11897-013-0148-6","article-title":"Relaxin for treatment of acute heart failure: making the case for treating targeted patient profiles","volume":"10","author":"JA Hernandez-Montfort","year":"2013","journal-title":"Current heart failure reports"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1152\/japplphysiol.00545.2003","article-title":"Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats","volume":"95","author":"LA Danielson","year":"2003","journal-title":"J Appl Physiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/HYPERTENSIONAHA.110.164392","article-title":"Relaxin ameliorates hypertension an increases nitric oxide metabolite excretion in angiotensin II but not N(\u03c9)-nitro-L-arginine methyl ester hypertensive rats","volume":"58","author":"JM Sasser","year":"2011","journal-title":"Hypertension"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1096\/fj.13-230797","article-title":"Treatment for cerebral small vessel disease: effect of relaxin on the function and structure of cerebral perenchymal arterioles during hypertension","volume":"27","author":"SL Chan","year":"2013","journal-title":"FASEB J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.peptides.2013.08.020","article-title":"Impaired effect of relaxin on vasoconstrictor reactivity in spontaneous hypertensive rats","volume":"49","author":"J van Drongelen","year":"2013","journal-title":"Peptides"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/01.HYP.0000184230.52059.33","article-title":"Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats","volume":"46","author":"DO Debrah","year":"2005","journal-title":"Hypertension"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"F1169","DOI":"10.1152\/ajprenal.00654.2012","article-title":"Relaxin protects against renal ischemia-reperfusion injury","volume":"305","author":"T Yoshida","year":"2013","journal-title":"American journal of physiology Renal physiology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2009.03.007","article-title":"Relaxin and its role in the development and treatment of fibrosis","volume":"154","author":"RG Bennett","year":"2009","journal-title":"Translational research: the journal of laboratory and clinical medicine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1152\/physrev.00001.2012","article-title":"Relaxin family peptides and their receptors","volume":"93","author":"RA Bathgate","year":"2013","journal-title":"Physiological reviews"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/HYPERTENSIONAHA.110.165027","article-title":"Angiogenic growth factors are new and essential players in the sustained relaxin vasodilatory pathway in rodents and humans","volume":"57","author":"JT McGuane","year":"2011","journal-title":"Hypertension"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCRESAHA.113.301646","article-title":"Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts","volume":"113","author":"A Parikh","year":"2013","journal-title":"Circulation research"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","article-title":"Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury","volume":"37","author":"A Fiebeler","year":"2001","journal-title":"Hypertension"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.HYP.0000171930.00697.2f","article-title":"Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats","volume":"46","author":"ED Lekgabe","year":"2005","journal-title":"Hypertension"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2174\/0929866511320090009","article-title":"The Anti-fibrotic Hormone Relaxin is not Reno-protective, Despite Being Active, in an Experimental Model of Type 1 Diabetes","volume":"20","author":"SE Wong","year":"2013","journal-title":"Protein and peptide letters"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1210\/en.2010-0286","article-title":"Antifibrotic properties of relaxin: in vivo mechanism of action in experimental renal tubulointerstitial fibrosis","volume":"151","author":"TD Hewitson","year":"2010","journal-title":"Endocrinology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/labinvest.2010.198","article-title":"Relaxin remodels fibrotic healing following myocardial infarction","volume":"91","author":"CS Samuel","year":"2011","journal-title":"Laboratory investigation; a journal of technical methods and pathology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/en.2007-1220","article-title":"Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis","volume":"149","author":"Q Xu","year":"2008","journal-title":"Endocrinology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/HJH.0b013e328352b89a","article-title":"Development of structural kidney damage in spontaneously hypertensive rats","volume":"30","author":"M Hultstrom","year":"2012","journal-title":"Journal of hypertension"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/ki.1986.76","article-title":"Relation of glomerular injury to preglomerular resistance in experimental hypertension","volume":"29","author":"JL Olson","year":"1986","journal-title":"Kidney international"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MNH.0b013e32831b7096","article-title":"Relaxin and the progression of kidney disease","volume":"18","author":"CS Samuel","year":"2009","journal-title":"Current opinion in nephrology and hypertension"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1749-6632.2008.03795.x","article-title":"Relaxin: an endogenous renoprotective factor?","volume":"1160","author":"TD Hewitson","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"key":"ref44","first-page":"F309","article-title":"Endothelial modulation of renal interlobar arteries from pregnant rats","volume":"265","author":"KC Griggs","year":"1993","journal-title":"Am J Physiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0093743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T21:05:53Z","timestamp":1588971953000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0093743"}},"subtitle":[],"editor":[{"given":"Ines","family":"Armando","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,7]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0093743","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,7]]}}}